BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/10/2023

FDA Clears ZOFRAN ODT Tablets for Sale

The FDA has ruled that ZOFRAN ODT orally disintegrating tablets, 4mg and 8mg, were not withdrawn due to safety or effectiveness concerns, allowing the agency to continue approving ANDA applications for these products.

Source: Federal Register — Food and Drug AdministrationOpen original release →